Clinical Trials

NCT04900623 | RECRUITING | PHASE2
145 participants

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2021-07-02
Completion:
2030-06-01
Conditions
  • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage
  • HPV-Related Squamous Cell Carcinoma
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage
  • HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Pathologic Stage
Interventions
  • DEVICE
  • RADIATION
  • DRUG
No Results Yet
NCT04539366 | SUSPENDED | PHASE1
73 participants

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2022-01-25
Completion:
2040-12-31
Conditions
  • Recurrent Childhood Neuroblastoma
  • Recurrent Childhood Osteosarcoma
  • Recurrent Neuroblastoma
  • Recurrent Osteosarcoma
  • Refractory Childhood Neuroblastoma
  • Refractory Childhood Osteosarcoma
  • Refractory Neuroblastoma
  • Refractory Osteosarcoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page